Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-Arterial Steroids for Acute GI GVHD
NCT02425813Phase 2Withdrawn
- Sponsor
- Wake Forest University Health Sciences
- Start
- Oct 2015
- Primary completion
- Jul 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of methylprednisolone sodium succinate in Acute Graft-Versus-Host Disease (aGvHD), sponsored by Wake Forest University Health Sciences. Planned start Oct 2015; status: withdrawn.
02
Drugs
methylprednisolone sodium succinate
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on NCT02425813.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02425813.